GENENCOR INTERNATIONAL, INC.
Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)     July 29, 2004

Genencor International, Inc.


(Exact name of registrant as specified in charter)
         
Delaware   000-31167   16-1362385

(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)
         
925 Page Mill Road, Palo Alto, California
    94304  

(Address of principal executive offices)
  (Zip Code)

Registrant’s telephone number, including area code     (650) 846-7500


(Former name or former address, if changed since last report)



 


TABLE OF CONTENTS

Item 7. Financial Statements and Exhibits.
Item 12. Results of Operations and Financial Condition.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1 PRESS RELEASE


Table of Contents

Item 7. Financial Statements and Exhibits.

     (c) Exhibits

     The following exhibit is furnished pursuant to Item 12:

     Exhibit 99.1 —   Press release issued by Genencor International, Inc. on July 29, 2004 regarding its financial results for the second quarter of 2004.

Item 12. Results of Operations and Financial Condition.

     The information contained in this report is being “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act.

     On July 29, 2004, Genencor International, Inc. (the “Company”) issued a press release regarding its financial results for the quarter and six months ended June 30, 2004. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

         
  GENENCOR INTERNATIONAL, INC.
 
 
Dated: July 29, 2004  By:   /s/ Raymond J. Land  
    Raymond J. Land,   
    Senior Vice President and
Chief Financial Officer 
 
 

 


Table of Contents

EXHIBIT INDEX

     
Exhibit Number
  Description
99.1
  Press release issued by Genencor International, Inc. on July 29, 2004 regarding its financial results for the second quarter of 2004.